OTC Pharmaceuticals - D-A-CH

D-A-CH

Revenue in the OTC Pharmaceuticals market amounts to US$13.31bn in 2024. The market is expected to grow annually by 2.91% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$5.32bn in 2024.
In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
In relation to total population figures, per person revenues of US$131.60 are generated in 2024.
In the OTC Pharmaceuticals market, 15.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in D-A-CH, consisting of Germany, Austria, and Switzerland, is experiencing steady growth due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market.

Customer preferences in the D-A-CH region play a significant role in shaping the OTC Pharmaceuticals market. Consumers in these countries tend to value convenience and accessibility when it comes to healthcare products. They prefer self-medication and are more inclined to purchase over-the-counter products for minor ailments and common health issues.

This preference for easy access to medication drives the demand for OTC Pharmaceuticals. Trends in the market further support the growth of the OTC Pharmaceuticals market in D-A-CH. One notable trend is the increasing focus on preventive healthcare.

Consumers are becoming more proactive in managing their health and are willing to invest in products that promote wellness and prevent illnesses. This trend has led to the introduction of a wide range of OTC Pharmaceuticals that cater to preventive healthcare needs, such as vitamins, supplements, and immune-boosting products. Another trend in the market is the growing popularity of natural and herbal remedies.

Consumers in the D-A-CH region have shown a preference for products with natural ingredients, as they perceive them to be safer and more sustainable. This has led to the development of a niche market for natural OTC Pharmaceuticals, including herbal supplements, homeopathic remedies, and alternative medicine products. Local special circumstances also contribute to the growth of the OTC Pharmaceuticals market in D-A-CH.

The healthcare systems in these countries are well-developed, with a strong emphasis on self-care and self-medication. This encourages consumers to seek OTC solutions for minor health issues, reducing the burden on healthcare professionals and the overall healthcare system. Additionally, the presence of a large aging population in the region increases the demand for OTC Pharmaceuticals, as older individuals are more likely to require medication for chronic conditions and age-related ailments.

Underlying macroeconomic factors further support the development of the OTC Pharmaceuticals market in D-A-CH. The region has a stable economy and high disposable income levels, allowing consumers to afford OTC medications. Additionally, the strong pharmaceutical industry in the region ensures a wide range of OTC products are available to meet consumer demand.

Overall, the OTC Pharmaceuticals market in D-A-CH is growing due to customer preferences for convenience and accessibility, trends in preventive healthcare and natural remedies, local special circumstances promoting self-medication, and favorable macroeconomic factors. This market is expected to continue expanding as consumers prioritize self-care and seek accessible healthcare solutions for their everyday needs.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.